Medmen Enterprises Inc

Most Recent

  • Tilray asks for shareholder vote for share count increase
    Cannabis

    Tilray Goes SNDL's Way and Bets on Marijuana Legalization With MedMen

    By Mohit Oberoi, CFA
  • uploads///ITHUF_
    Company & Industry Overviews

    iAnthus to Open Three Dispensaries in Florida by End of 2018

    Today, iAnthus Capital Holdings (ITHUF) announced it will open its first dispensary in Florida on December 19.

    By Rajiv Nanjapla
  • uploads///medmen upcoming results
    Cannabis

    Will MedMen Deliver Any Good News in Its Q2 Earnings?

    MedMen will report its earnings results for the second quarter of fiscal 2020 on Wednesday. Analysts expect 67.6% YoY revenue growth.

    By Sushree Mohanty
  • uploads///trump
    Cannabis

    Elizabeth Warren Unveils Plan for Marijuana Legalization

    According to Warren’s new marijuana plan, the federal legalization process would start within 100 days of her taking office.

    By Sushree Mohanty
  • uploads///texas
    Cannabis

    Marijuana in Texas: Five Things You Should Know

    Marijuana laws are pretty strict in Texas, but could this change? Here are five things you need to know about the state’s relationship with marijuana.

    By Sushree Mohanty
  • uploads///Chart
    Company & Industry Overviews

    MedMen’s Must-Know Revenue Drivers

    MedMen’s (MMNFF) reported revenues are generated from direct sales through its retail stores. The company has reported no material revenues from cultivation or production wholesale operations.

    By Mike Benson
  • uploads///marijuana in june
    Cannabis

    Will Marijuana Stocks Continue to Surge in June?

    May was an earnings month for many marijuana companies. Notably, US companies showed better revenue growth than their Canadian peers.

    By Sushree Mohanty
  • uploads///marijuana
    Cannabis

    Marijuana: Why Did Mexico Delay Legalization?

    Mexico has delayed marijuana legalization. The Supreme Court’s deadline for legalization was October 23. The delay could stretch into November.

    By Sushree Mohanty
  • uploads///cresco labs earnings
    Cannabis

    Cresco Labs’ Q1 Earnings: Dazzling Growth amid COVID-19

    Cresco Labs reported its results for the first quarter of fiscal 2020 on May 28. The stock declined 4.2% and closed at $4.8 on the OTC markets yesterday.

    By Sushree Mohanty
  • uploads///medmen recovery
    Cannabis

    Did MedMen’s Q3 Earnings Start a Path to Recovery?

    MedMen released its results for the third quarter of fiscal 2020 on May 27. The stock declined 4.0% and closed at $0.35 on the OTC markets.

    By Sushree Mohanty
  • uploads///cannabis
    Cannabis

    Regulators Beware: Cannabis Linked to Job Loss

    Cannabis is slowly picking up steam again, with more states are pushing to legalize. However, it appears the challenges never end in the marijuana sector.

    By Sushree Mohanty
  • uploads///PLTH_
    Company & Industry Overviews

    Planet 13 Inks Deal with Mike Tyson’s Cannabis Venture

    Today, Planet 13 Holdings (PNTH) (PLNHF) announced that it had inked a purchase agreement with Tyson Ranch, which is owned by boxer Mike Tyson.

    By Rajiv Nanjapla
  • uploads///can
    Cannabis

    Cannabis Investing in 2019: A Year of Big Reversals

    The cannabis sector has seen a bit of a Jekyll and Hyde situation in 2019. In the first half, cannabis ETFs rose, but in the second half, they plummeted.

    By Rajiv Nanjapla
  • uploads///Acreage
    Cannabis

    Acreage: Analysts Lower Targets after Q3 Earnings

    Acreage Holdings (ACRG)(ACRGF) reported its third-quarter earnings after markets closed on November 12. Here’s how analysts have reacted since.

    By Rajiv Nanjapla
  • uploads///cresco labs
    Cannabis

    Why Origin House’s Acquisition Is Vital for Cresco Labs

    On December 31, 2019, Origin House (OH) announced that its shareholders had approved Cresco Labs’ (CRLBF) acquisition plan.

    By Rajiv Nanjapla
  • uploads///MedMen
    Cannabis

    MedMen: Analysts’ Views before Its Earnings

    MedMen’s disappointing fourth-quarter results caused the stock price to fall. The company missed analysts’ revenue estimates for the quarter.

    By Sushree Mohanty
  • uploads///AISC
    Cannabis

    Marijuana Legalization: ‘Make It Legal Florida!’

    Marijuana legalization is firing up. Currently, cannabis is legal for recreational use in ten states and Washington DC. Cannabis is legal for medical use in 33 states. Other states are also gearing up to legalize marijuana. Today, we’ll discuss how Florida is stepping up for cannabis legalization. “Make it legal, Florida!” Legalizing medical marijuana has […]

    By Adam Jones
  • uploads///Marijuana
    Cannabis

    Marijuana Sales Soar amid Coronavirus Pandemic

    Marijuana stocks are seeing a ray of hope amid the coronavirus pandemic. With self-quarantine and lockdowns in many cities, marijuana sales have risen.

    By Sushree Mohanty
  • uploads///curaleaf new jersey
    Cannabis

    Curaleaf Holdings Completes Curaleaf NJ’s Acquisition

    Curaleaf Holdings (OTCMKTS:CURLF) continued its expansion by completing the acquisition of Curaleaf NJ, which owns a medical license in New Jersey.

    By Rajiv Nanjapla
  • uploads///green thumb store
    Cannabis

    Green Thumb Keeps Expanding Its Operations in Las Vegas

    On June 27, Green Thumb Industries (OTCMKTS:GTBIF) opened its fifth Essence brand store in Las Vegas and its 48th retail store in the US.

    By Rajiv Nanjapla
  • uploads///illinois cannabis growth
    Cannabis

    Cannabis Market in Illinois Grows, Challenges Remain

    The growth in Illinois’s cannabis market is evident from its record sales in May. The state sold adult-use cannabis worth $44.3 million in May.

    By Sushree Mohanty
  • uploads///medmen relief
    Cannabis

    MedMen’s Medical Marijuana Dispensary License Revoked in Virginia

    The Virginia Board of Pharmacy voted not to extend MedMen’s conditional license to operate a medical marijuana dispensary in Staunton, Virginia.

    By Rajiv Nanjapla
  • uploads///Curaleaf
    Cannabis

    Curaleaf Expands Select Brand Medical Products in Connecticut

    On Monday, Curaleaf Holdings announced that it will expand its Select brand products in Connecticut. The products will be available at medical dispensaries.

    By Rajiv Nanjapla
  • uploads///iipr earnings
    Cannabis

    IIPR Acquires Another Property in Pennsylvania

    Innovative Industrial Properties has continued its aggressive expansion. IIPR acquired a new property in Pennsylvania from Holistic Industries.

    By Rajiv Nanjapla
  • uploads///cannabis
    Cannabis

    Illinois Reports Record Recreational Cannabis Sales in May

    Illinois sold recreational cannabis worth $44.3 million in May—the highest amount since it legalized recreational sales in January this year.

    By Rajiv Nanjapla
  • uploads///green thumb industries
    Cannabis

    Green Thumb Industries Opens Its 46th Retail Store

    On Monday, Green Thumb Industries (OTCMKTS:GTBIF) opened a Rise brand store in Chambersburg, Pennsylvania—its 46th store in the US.

    By Rajiv Nanjapla
  • uploads///Vireo Health
    Cannabis

    Vireo Health Terminates Bruce Linton as Its Executive Chairman

    On Monday, Vireo Health announced that it terminated Bruce Linton as its executive chairman immediately. He joined the company in November 2019.

    By Rajiv Nanjapla
  • uploads///cannabis illinois
    Cannabis

    Cannabis Market Has Good Potential in Illinois

    The cannabis market in Illinois has been growing despite the COVID-19 pandemic. Illinois legalized recreational cannabis on January 1, 2020.

    By Sushree Mohanty
  • uploads///cresco labs estimates
    Cannabis

    Cresco Labs: Analysts Revise 2020 Estimates after Earnings

    Cresco Labs (OTCMKTS:CRLBF) is one of the US cannabis companies that has been consistently performing well despite the marijuana industry’s struggles.

    By Sushree Mohanty
  • uploads///medmen stores closed
    Cannabis

    MedMen Temporarily Closes Stores amid Protests

    Amid the protests following George Floyd’s death in the US, MedMen temporarily closed all of its stores. The stock fell after the news.

    By Sushree Mohanty
  • uploads///new mexico marijuana legalization
    Cannabis

    Marijuana Legalization Might Bring Economic Relief in New Mexico

    Governor Grisham thinks that marijuana is a good option to help New Mexico recover from the economic losses amid COVID-19.

    By Sushree Mohanty
  • uploads///green thumb industries good bet
    Cannabis

    Why Green Thumb Industries Is a Good Cannabis Bet

    So far in 2020, Green Thumb Industries has returned 6.0%—one of the few cannabis companies with positive returns this year.

    By Rajiv Nanjapla
  • uploads///medmen relief
    Cannabis

    Will MedMen’s Q3 2020 Earnings Be a Relief?

    MedMen Enterprises (OTCMKTS:MMNFF) is scheduled to report its financial results for the third quarter of fiscal 2020 on May 27 after the market closes.

    By Sushree Mohanty
  • uploads///curaleaf q earnings
    Cannabis

    Why Did Curaleaf Report a Mixed Q1 Performance?

    On Monday, Curaleaf (OTCMKTS:CURLF) reported its first-quarter earnings after the market closed. The company reported revenue of $96.5 million.

    By Rajiv Nanjapla
  • uploads///cweb_
    Cannabis

    Why Curaleaf Is a ‘Buy’ before Its Q1 Earnings

    Analysts expect Curaleaf’s EBITDA to rise during the quarter. They expect the company to report an EBITDA of $15.7 million.

    By Rajiv Nanjapla
  • uploads///charlottes web upcoming earnings
    Cannabis

    Why Analysts Are Bullish before Charlotte’s Web’s Q1 Earnings

    Charlotte’s Web Holdings (OTCMKTS:CWBHF)(NYSEARCA:CWEB) will likely report its first-quarter earnings before the market opens on May 14.

    By Rajiv Nanjapla
  • uploads///iipr earnings
    Cannabis

    IIPR Stock Falls after Reporting Weak Q1 Performance

    On May 6, Innovative Industrial Properties reported its first-quarter results after the market closed. The company posted an adjusted EPS of $0.72.

    By Rajiv Nanjapla
  • uploads///CRON_
    Cannabis

    Should You Buy IIPR before Its Q1 Earnings?

    IIPR will likely report its first-quarter earnings, which ended on March 31, after the market closes on May 6. So, should you buy the stock?

    By Rajiv Nanjapla
  • uploads///cresco labs stock price
    Cannabis

    Is There More Upside to Cresco Labs’ Stock Price?

    Amid the weakness in the global financial markets due to the COVID-19 outbreak, Cresco Labs fell to a low of 2.81 Canadian dollars on March 17.

    By Rajiv Nanjapla
  • uploads///curaleaf target price
    Cannabis

    Analysts Cut Curaleaf’s Target Price after Its Q4 Earnings

    Since Curaleaf reported its fourth-quarter earnings on March 24, Alliance Global Partners and Canaccord Genuity have lowered their target prices.

    By Rajiv Nanjapla
  • uploads///curaleaf earnings results
    Cannabis

    Curaleaf Reports Impressive Q4 Earnings Results

    On Tuesday, Curaleaf (OTCMKTS:CURLF) reported its fourth-quarter earnings after the market closed. The company reported revenue of $75.46 million.

    By Rajiv Nanjapla
  • uploads///curaleaf beat expectations
    Cannabis

    Will Curaleaf Beat Analysts’ Expectations in Q4?

    Curaleaf Holdings (OTCMKTS:CURLF) will report its fourth-quarter earnings after the market closes on March 24. Analysts are bullish on Curaleaf.

    By Rajiv Nanjapla
  • uploads///curaleaf upcoming results
    Cannabis

    Analysts Recommend a ‘Buy’ for Curaleaf before Its Q4 Earnings

    As of Thursday, nine analysts covered Curaleaf. Among the analysts, eight recommend a “buy,” while one recommends a “hold.”

    By Rajiv Nanjapla
  • uploads///cannabis us coronavirus
    Cannabis

    Is the Coronavirus Impacting US Cannabis Sales?

    The US cannabis industry has experienced lower sales amid the coronavirus chaos. The US stock market closed with a loss of 1.6% on March 6.

    By Sushree Mohanty
  • uploads///Green Growth
    Cannabis

    Charlotte’s Web Reports Improved Yield and CBD Potency

    On Wednesday, Charlotte’s Web Holdings (NYSEARCA:CWEB) announced that the audit of its 2019 hemp harvest is complete.

    By Rajiv Nanjapla
  • uploads///tilray target price cut
    Cannabis

    Tilray’s Q4 Earnings Force Analysts to Cut Its Target Price

    Tilray (NASDAQ:TLRY) reported dismal results for the fourth quarter of fiscal 2019 on Tuesday. The losses widened in the fourth quarter.

    By Sushree Mohanty
  • uploads///connecticut marijuana public
    Cannabis

    Connecticut Will Hear Public’s View on Marijuana Legalization

    Marijuana legalization is a hot top topic in the US as the presidential 2020 election gets closer. Legalization is a priority for Connecticut in 2020.

    By Sushree Mohanty
  • uploads///curaleaf bluekudu
    Cannabis

    How Will Curaleaf Benefit from Acquiring BlueKudu?

    On Monday, Curaleaf (OTCMKTS:CURLF) announced that it will acquire BlueKudu—a company that produces premium cannabis chocolates and gummies.

    By Rajiv Nanjapla
  • uploads///acreage holdings stock
    Cannabis

    Acreage Holdings’ Q4 Results Dragged Its Stock Down

    Acreage Holdings stock fell after its fourth-quarter earnings results. The company reported its results on Tuesday after the market closed.

    By Sushree Mohanty
  • uploads///gw pharmaceuticals target price cut
    Cannabis

    Analysts Cut GW Pharmaceuticals’s Target Price after Q4 Earnings

    On Tuesday, GW Pharmaceuticals reported its fourth-quarter earnings. The company reported revenue of $109.1 million, which beat analysts’ expectations.

    By Rajiv Nanjapla
  • uploads///CBD_
    Cannabis

    IIPR Posts Impressive Q4 Earnings, Looks Strong in 2020

    On Wednesday, IIPR reported its fourth-quarter earnings. The company reported revenues of $17.7 million, which beat analysts’ expectations of $14.4 million.

    By Rajiv Nanjapla
  • uploads///acreage holdings results
    Cannabis

    Will Acreage Holdings’ Q4 Results Help Its Stock?

    Acreage Holdings will report its fourth-quarter and fiscal 2019 results today after the market closes. Analysts expect the company to report revenue growth.

    By Sushree Mohanty
  • uploads///cannabis_
    Cannabis

    Green Growth Brands Reported Mixed Q2 Performance

    On Monday, Green Growth Brands reported its earnings results for the second quarter of fiscal 2020. The company reported revenues of $21.1 million.

    By Rajiv Nanjapla
  • uploads///APHA_
    Cannabis

    Has Cresco Labs Bottomed Out in 2020?

    As of Tuesday, Cresco Labs was trading at 6.73 Canadian dollars, which represents a fall of 24.6% since the beginning of the year.

    By Rajiv Nanjapla
  • uploads///curaleaf__
    Cannabis

    Beacon Securities Is Still Bullish on Curaleaf

    After Curaleaf completed the acquisition of the Select brand, Russell Stanley of Beacon Securities reiterated his “buy” rating.

    By Rajiv Nanjapla
  • uploads///curaleaf__
    Cannabis

    Why Beacon Securities Is Bullish on Curaleaf

    On Monday, Russell Stanley of Beacon Securities reiterated his “buy” rating for Curaleaf Holdings. He gave a target price of 25 Canadian dollars.

    By Rajiv Nanjapla
  • uploads///GW Pharmaceuticals
    Cannabis

    GW Pharmaceuticals Provides Preliminary Sales Update

    On January 12, GW Pharmaceuticals announced its preliminary unaudited product sales report for the fourth quarter and 2019.

    By Rajiv Nanjapla
  • uploads///Graphics
    Cannabis

    Why Did MedMen and PharmaCann Call it Off?

    On October 8, MedMen Enterprises (MMEN) (MMNFF) announced that it would not buy PharmaCann. Both parties decided to call off this all-stock transaction. MedMen valued PharmaCann at $682 million. The company planned to fund the deal through equity dilution. Once the deal was complete, PharmaCann shareholders would account for 25% ownership in the new combined […]

    By Margaret Patrick
  • uploads///cannabis
    Cannabis

    ‘Make It Legal Florida’ Cannabis Campaign’s Next Step

    Florida’s “Make It Legal Florida” measure could push other states to look at cannabis legalization. However, President Trump doesn’t seem supportive.

    By Sushree Mohanty
  • uploads///Vaping
    Cannabis

    Joe Biden Wants More Research on Vaping

    Democratic nominee Joe Biden thinks e-cigarette sales should only be allowed after scientific analysis of the products’ long-term impact on health.

    By Rajiv Nanjapla
  • uploads///cresco_
    Cannabis

    Why Beacon Securities Thinks Cresco Labs Is Cheap

    Russell Stanley of Beacon Securities is optimistic about Cresco Labs (CRLBF) in the cannabis space. He maintained the “buy” rating and target price.

    By Rajiv Nanjapla
  • uploads///Curaleaf
    Cannabis

    What Analysts Think About Curaleaf in Fiscal 2020

    Curaleaf (CURLF) seems to be in a good position in 2019 compared to other cannabis players. Can it keep up its performance in 2020?

    By Sushree Mohanty
  • uploads///can_
    Cannabis

    What’s Driving Cannabis Stocks Today?

    Boosted by the strong performance from the broader equity market, the cannabis sector was trading in the green today.

    By Rajiv Nanjapla
  • uploads///Chart  Valuation
    Cannabis

    Understanding MedMen’s Cannabis Logistics Software

    Cannabis retailer MedMen Enterprises (MMNFF) has partnered with Onfleet software to handle its multistate logistics.

    By Nivedha Elango
  • uploads///can_
    Cannabis

    Cannabis Sector Rounds Out the Week in the Green

    Yesterday, Ontario’s government announced that it was scrapping its cap on the number of private retail cannabis stores and moving toward a new system.

    By Rajiv Nanjapla
  • uploads///MedMen
    Cannabis

    Why MedMen Stock Rose More than 24% on Thursday

    The optimistic guidance and initiatives helped MedMen stock rise. On Thursday, the stock closed the day at 0.71 Canadian dollars.

    By Rajiv Nanjapla
  • uploads///cannabis
    Cannabis

    A Deep Dive into the Top Cannabis Retailers in Florida

    Since Florida legalized medical marijuana, business is booming. In September, the state had 22 licensed vertically integrated medical cannabis operators.

    By Sushree Mohanty
  • uploads///
    Cannabis

    MedMen: Price Targets and Ratings after Q1 Earnings

    There have been no rating changes since MedMen reported its Q1 earnings. Six of eight analysts gave the stock a “hold” rating.

    By Rajiv Nanjapla
  • uploads///Marijuana
    Cannabis

    Marijuana Legalization: Can Virginia Expect it in 2020?

    Marijuana is strictly prohibited in Virginia. All forms of marijuana are illegal in the state. Yet, recreational sales went live in Michigan on Sunday.

    By Sushree Mohanty
  • uploads///marijuana
    Cannabis

    Marijuana in Hawaii: Is Further Legalization Likely?

    We’ve previously discussed the varying degrees of marijuana legalization in a variety of US states. Now, let’s talk about the laws in Hawaii.

    By Sushree Mohanty
  • Cannabis

    How MedMen Is Staking Its Claim in Cannabis Retail

    Major US cannabis retailer MedMen aims to expand its brand by increasing its number of flagship retail stores and offering high-quality cannabis products.

    By Nivedha Elango
  • uploads///FDA
    Cannabis

    Analysts Believe the FDA Will Get Tough on CBD

    Earlier this week, the FDA announced that it couldn’t conclude CBD was safe. It warned the public of various risks linked to CBD usage.

    By Rajiv Nanjapla
  • uploads///MedMen
    Cannabis

    Key Takeaways from MedMen’s First-Quarter Earnings

    Cannabis retailer MedMen (MMNFF)(MMEN) reported its first quarter of fiscal 2020 earnings results yesterday. Here’s what you need to know.

    By Sushree Mohanty
  • uploads///cannabis
    Cannabis

    Cannabis Is Up Today: The Latest from CGC and Its Peers

    The cannabis sector is in the green today. At 12:58 PM ET, the ETFMG Alternative Harvest ETF and Horizons Marijuana Life Sciences Index ETF were up 0.8%.

    By Rajiv Nanjapla
  • uploads///cresco labs
    Cannabis

    Can Cresco Lab’s Q3 Earnings Drive the Cannabis Sector?

    As of November 22, Cresco Labs was trading at 7.65 Canadian dollars, which implies a fall of 30% since its second-quarter earnings on August 21.

    By Rajiv Nanjapla
  • uploads///AdobeStock_
    Cannabis

    California Tightens Noose around Cannabis Industry

    California’s legal cannabis market spending will rise from $3.1 billion in 2019 to $7.2 billion in 2024. The market could be $11.0 billion by 2030.

    By Margaret Patrick
  • uploads///AdobeStock_
    Cannabis

    NHS Approves Cannabis Medicines: Market Impact

    On November 11, the NHS (National Health Service) approved two cannabis-based medicines, Epidyolex and Sativex, for use in the United Kingdom.

    By Margaret Patrick
  • uploads///AdobeStock_
    Cannabis

    MedMen Fights for Survival amid Sector Meltdown

    On November 15, MedMen (MMEN) (MMNFF) declared an extensive five-year restructuring plan in its attempt to become EBITDA-positive by 2020.

    By Margaret Patrick
  • uploads///can
    Cannabis

    Cannabis Stocks Continue to Tremble after Earnings

    Last week, three prominent cannabis companies—Cronos Group (CRON), Aurora Cannabis (ACB), and Canopy Growth (CGC)(WEED)—reported earnings results.

    By Rajiv Nanjapla
  • uploads///charlottes web
    Cannabis

    Charlotte’s Web: Analysts Cut Targets after Weak Q3

    Charlotte’s Web Holdings reported its fiscal 2019 third-quarter earnings results on November 13. Its revenue came in at $25.1 million.

    By Rajiv Nanjapla
  • uploads///
    Cannabis

    Charlotte’s Web: Q3 Earnings Missed Analysts’ Estimates

    Today, Charlotte’s Web Holdings (CWEB) (CWBHF) reported its third-quarter earnings. The company missed analysts’ revenue and EPS estimates.

    By Rajiv Nanjapla
  • uploads///
    Cannabis

    Why Cannabis Stocks Are in the Red Today

    The cannabis sector was trading in the red today. MKM Partners lowered its revenue estimates for Canopy Growth (CGC) (WEED) and Aurora Cannabis (ACB).

    By Rajiv Nanjapla
  • uploads///cweb
    Cannabis

    Charlotte’s Web: What to Expect from Q3 Earnings

    Charlotte’s Web Holdings (CWEB) (CWBHF) will report third-quarter earnings before the market opens on November 13. Let’s look at analysts’ expectations.

    By Rajiv Nanjapla
  • uploads///curaleaf
    Cannabis

    Curaleaf Launches Adult-Use Cannabis in MA

    Yesterday, Curaleaf Holdings (CURLF) (CURA) opened its first recreational or adult-use dispensary in Massachusetts at Oxford.

    By Rajiv Nanjapla
  • uploads///CB
    Cannabis

    Charlotte’s Web: Top Four Things to Know about the Stock

    Last month, Charlotte’s Web announced that it would partner with Nielsen to guide US retail companies on the growth of the CBD (cannabidiol) space.

    By Rajiv Nanjapla
  • uploads///can_
    Cannabis

    Cannabis Stocks in the Green alongside S&P 500

    Investors’ optimism about a US–China trade deal helped the market trade in the green today—and cannabis stocks are also trending higher. Here’s why.

    By Rajiv Nanjapla
  • uploads///TJX Sales
    Cannabis

    MedMen Buds: Loyalty Program Information

    MedMen (MMNFF) is a vertically integrated cannabis retailer with its footprint across the US. The company is in nine states and has 32 stores and 70 retail licenses. Recently, the company launched a loyalty program called MedMen buds. Also, the company launched its omnichannel delivery services in August. What is MedMen Buds? MedMen Buds is […]

    By Nivedha Elango
  • uploads///HEXO_
    Cannabis

    HEXO: Analysts Downgrade, But Stock Rises 1%

    HEXO Corp. (HEXO) reported its Q4 earnings of fiscal 2019. The company posted revenues of $15.42 million Canadian dollars.

    By Rajiv Nanjapla
  • uploads///AdobeStock_
    Cannabis

    Marijuana in Florida: Five Things You Should Know

    Florida is the second-fastest adopter of medical marijuana. The state reports an average increase of 609 medical marijuana patients on a daily basis.

    By Margaret Patrick
  • uploads///MedMen_
    Cannabis

    MedMen: Stock Falls over 20% after Q4 2019 Earnings

    MedMen Enterprises (MMEN) (MMNFF) reported its fourth-quarter earnings that ended on June 30. The company reported revenues of $41.97 million.

    By Rajiv Nanjapla
  • uploads///AdobeStock_
    Cannabis

    How Marijuana Legalization May Boost Florida’s Economy

    Right now, medical marijuana is legal in 33 states. Florida is one state that may aggressively push for recreational marijuana legalization in 2020.

    By Margaret Patrick
  • uploads///MMEN
    Cannabis

    MedMen: Analysts’ Lower Target Price and Ratings

    October has been tough for the cannabis sector. As of Monday, MedMen was trading at 1.58 Canadian dollars, which represents a fall of 18.6% this year.

    By Rajiv Nanjapla
  • uploads///
    Cannabis

    Cannabis Roundup: MMEN, APHA, ACB, and TGOD

    The US markets rose on optimism surrounding US-China trade talks. However, weakness in the cannabis sector led the cannabis ETFs trading in the red.

    By Rajiv Nanjapla
  • uploads///can_
    Cannabis

    Cannabis Roundup: HEXO, MMEN, WEED, and CRON

    At 1:40 PM ET, the S&P 500 and the Dow Jones Industrial Average were up 0.2% and 0.3%, respectively. However, cannabis ETFs were trading in the red.

    By Rajiv Nanjapla
  • uploads///
    Cannabis

    Will Cannabis Stocks Bleed More? MKM Weighs In

    This year, the cannabis sector has been underperforming the broader equity market. Will cannabis stocks bleed more after MKM Partners’ bearish outlook?

    By Rajiv Nanjapla
  • uploads///
    Cannabis

    Cannabis Roundup: STZ, CURLF, MMNFF, and ACB

    Today, the US markets were trading in the green on the expectation of rate cuts. The cannabis ETFs and the majority of cannabis stocks were also up today.

    By Rajiv Nanjapla
  • uploads///medmen
    Cannabis

    MedMen: Analysts’ Target Price and Ratings

    After MedMen reported its preliminary fourth-quarter earnings, Cormark Securities reduced the target price to 6.5 Canadian dollars from 7.5 Canadian dollars.

    By Sushree Mohanty
  • uploads///
    Miscellaneous

    Cannabis Roundup: MMEN, APHA, CRON, and ACB

    With today’s decline in September’s Consumer Confidence Index, the broader equity markets and the cannabis sector took a hit as well.

    By Rajiv Nanjapla
  • uploads///cannabis_
    Cannabis

    Cannabis Roundup: MMEN, ACB, WEED, and CTST

    Today at 2:10 PM ET, the S&P 500 Index fell 0.3% as investors watched rising oil prices. The cannabis sector also fell today, as its ETFs traded in the red.

    By Rajiv Nanjapla
  • uploads///cannabis
    Cannabis

    Cannabis Coverage by Cowen: Cresco, Curaleaf, Acreage

    Despite Aurora Cannabis’s subdued results, Cowen initiated coverage on five cannabis stocks: CRLBF, GTBIF, CURLF, MMNFF, and ACRGF.

    By Sushree Mohanty
    • CONNECT with Market Realist
    • Link to Facebook
    • Link to Twitter
    • Link to Instagram
    • Link to Email Subscribe
    Market Realist Logo
    Do Not Sell My Personal Information

    © Copyright 2021 Market Realist. Market Realist is a registered trademark. All Rights Reserved. People may receive compensation for some links to products and services on this website. Offers may be subject to change without notice.